Chemical structure
Cat.No.
Product Name
CAS no.
Target
YN320121 S1p receptor agonist 1 1514888-56-2
S1p receptor agonist 1 is a potent and orally activeS1P receptoragonist, exhibits an activity of inducing S1P1 internalization (EC50=9.83nM). S1p receptor agonist 1 has the potential for the study of arthritis and EAE (expe...
ML355 is a potent and selective inhibitor of human 12-Lipoxygenase with an IC50 of 290 nM and shows excellent selectivity over related lipoxygenases and cyclooxygenases.
YN330093 Avelumab 1537032-82-8
Avelumab is a fully human IgG1 anti-PD-L1monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity.
SBFI-26 is a selective and competitive inhibitor of fatty acid binding proteinsFABP5 and FABP7, with Kis of 0.9 µM and 0.4 µM for FABP5 and FABP7, respectively. SBFI-26 produces anti-nociceptive and anti...
YN372542 ZED-1227 1542132-88-6
ZED-1227 is a specific and oraltransglutaminase 2 (TG2)inhibitor, with an IC50 of 45nM. ZED-1227 can block inflammation-induced TG2 expression and activity. ZED-1227 can be used for the research of celiac disease (CeD...
YN440041 Btk inhibitor 2 1558036-85-3
Btk inhibitor 2 is a BTK inhibitor.
YN310145 BJE6-106 1564249-38-2
BJE6-106 (B106) is a potent, selective 3rdgenerationPKCδinhibitor with an IC50 of 0.05μM and targets selectivity over classical PKC isozyme PKCα (IC50=50μM). BJE6-106 (B106) induces caspase-dependentapoptosis. ...
PS10 is a novel, potent and ATP-competitive pan-PDKinhibitor, inhibits all PDK isoforms with IC50 of 0.8μM, 0.76μM, 2.1μM and 21.3μM for PDK2, PDK4, PDK1, and PDK3, respectively. PS10 shows high affi...
PRN694 is an irreversible, highly selective and potent covalentinterleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK)dual inhibitor with IC50s of 0.3nM and 1.4nM, respectively. PRN694 exhibits e...
YN270110 GSK2983559 free acid 1579965-12-0
GSK2983559 is a potent inhibitor of receptor interacting protein 2 (RIP2) kinase with good kinase specificity.
kira6 is a potent type II IRE1α kinase inhibitor with an IC50 of 0.6 μM. It dose-dependently inhibits IRE1α(WT) kinase activity, XBP1 RNA cleavage, Ins2 RNA cleavage and oligomerization.
GSK717 is a potent, selectiveNOD2(nucleotide-binding oligomerization domain 2) inhibitor. GSK717 inhibits muramyl dipeptide (MDP)-induced NOD2-mediated signaling, with an IC50 of 400nM for MDP-stimulated IL-8 secretio...
YN320430 PS372424 hydrochloride 1596362-29-6
PS372424 hydrochloride, a three amino-acid fragment of CXCL10, is a specific humanCXCR3agonist with anti-inflammatory activity. PS372424 hydrochloride prevents human T-cell migration in a humanized model of arthritic inflammati...
ML401, a potent chemical probe, selectively antagonizesEBI2(also known asGPR183) with an IC50 of 1.03nM. ML401 displays activity in a chemotaxis assay (IC50=6.24nM). ML401 shows good stability and no toxicity.
NIBR189 is a small molecule antagonist of the Epstein-Barr virus-induced gene 2 (EBI2; GPR183) receptor with IC50 of 16nM(Binding) and 11nM (Functional). NIBR189 is a potent and selective EBI2 antagonist with im...
GSK-843 (GSK'843) is areceptor-interacting protein kinase 3 (RIP3 or RIPK3)inhibitor, which binds RIP3 kinase domain with an IC50 of 8.6nM, and inhibits kinase activity with an IC50 of 6.5nM.
AZD3264 is a novel IKK2 inhibitor.
YN330156 BMS-986165 1609392-27-9
BMS-986165 is a highly selective, orally bioavailable allostericTYK2inhibitor for the treatment of autoimmune diseases, which selectively binds to TYK2 pseudokinase (JH2) domain (IC50=1.0nM) and blocks receptor-...
YN410043 Aeruginosin 865 1611990-01-2
Aeruginosin 865, isolated from terrestrial cyanobacteriumNostoc sp. Lukešová 30/93, is the first aeruginosin-type peptide containing both a fatty acid and a carbohydrate moiety. Aeruginosin 865 inhibits translocation ofNF-kBto th...
BAR502 is a dualFXR and GPBAR1agonist with IC50 values of 2μM and 0.4μM, respectively.
TELL : +86-020-82000279
Add:Room 519, Block F, Guangzhou International Business Incubator, No.3 Lanyue Road, Science Town, Huangpu District, Guangzhou, China.